SKI Market

Indian Indices

Nifty

22,502.00 35.90
(0.16%)

Sensex

74,005.94 88.91
( 0.12%)

Bank Nifty

48,199.50 83.85
( 0.17%)

Nifty IT

33,438.75 56.90
( 0.17%)

Global Indices

Nasdaq

16,685.97 -12.35
(-0.07%)

Dow Jones

40,003.59 134.21
(0.34%)

Hang Seng

19,553.61 177.08
(0.91%)

Nikkei 225

38,787.38 -132.88
(-0.34%)

Forex

USD-INR

83.47 0.01
(0.01%)

EUR-INR

90.76 0.22
(0.25%)

GBP-INR

105.79 0.36
(0.34%)

JPY-INR

0.54 0.00
(0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Shree Ganesh Biotech India Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

539470

INE051N01026

1.5699306

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

120

47.83

EPS(TTM)

Face Value()

Div & Yield %

0.01

Back

shree ganesh biotech india ltd

Shree Ganesh Biotech India standalone net profit declines 66.67% in the December 2023 quarter

Feb 14,2024

Net profit of Shree Ganesh Biotech India declined 66.67% to Rs 0.09 crore in the quarter ended December 2023 as against Rs 0.27 crore during the previous quarter ended December 2022. Sales declined 65.87% to Rs 4.12 crore in the quarter ended December 2023 as against Rs 12.07 crore during the previous quarter ended December 2022.

Particulars	Quarter Ended
	Dec. 2023	Dec. 2022	% Var.
Sales	4.12	12.07	-66
OPM %	2.18	2.24	-
PBDT	0.09	0.27	-67
PBT	0.09	0.27	-67
NP	0.09	0.27	-67

22,502.00 35.90 (0.16%)

74,005.94 88.91 ( 0.12%)

48,199.50 83.85 ( 0.17%)

33,438.75 56.90 ( 0.17%)

16,685.97 -12.35 (-0.07%)

40,003.59 134.21 (0.34%)

19,553.61 177.08 (0.91%)

38,787.38 -132.88 (-0.34%)

83.47 0.01 (0.01%)

90.76 0.22 (0.25%)

105.79 0.36 (0.34%)

0.54 0.00 (0.51%)